We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
AUM
$369M
AUM Growth
+$131M
Cap. Flow
+$128M
Cap. Flow %
34.58%
Top 10 Hldgs %
99.8%
Holding
12
New
1
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
VTV icon
Vanguard Value ETF
VTV
+$97.8M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$30M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$220M 59.53%
2,990,084
+411,900
+16% +$30M
VTV icon
2
Vanguard Value ETF
VTV
$186B
$99.3M 26.88%
+520,000
New +$97.8M
INDA icon
3
iShares MSCI India ETF
INDA
$6.83B
$20M 5.41%
369,600
FHTX icon
4
Foghorn Therapeutics
FHTX
$305M
$8.5M 2.3%
1,573,761
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.11B
$8.09M 2.19%
989,410
PMVP icon
6
PMV Pharmaceuticals
PMVP
$71.5M
$3.28M 0.89%
2,627,643
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$2.8M 0.76%
4,104
RAPT
8
DELISTED
RAPT Therapeutics
RAPT
$2.79M 0.75%
82,234
ALEC icon
9
Alector
ALEC
$167M
$2.04M 0.55%
1,307,858
SRZN icon
10
Surrozen
SRZN
$255M
$1.98M 0.54%
87,696
TNYA icon
11
Tenaya Therapeutics
TNYA
$177M
$723K 0.2%
1,015,705
SRZNW icon
12
Surrozen Inc Warrant
SRZNW
$3.42K ﹤0.01%
170,833

Similar funds

Euclidean Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Euclidean Capital held 12 positions worth $369M, up 55% from $238M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital deployed $128M of net new capital in Q4 2025, opening 1 new position and adding to 1 existing holding. Its largest new stake was Vanguard Value ETF: 520,000 shares worth $99.3M.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, down from 13% a quarter earlier.

  • Euclidean Capital's largest Q4 2025 buy was Vanguard Value ETF: 520,000 shares worth $99.3M.
  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q4 2025, an estimated $30M increase.
  • Euclidean Capital's ten largest holdings make up 100% of its $369M portfolio in Q4 2025.
  • Euclidean Capital opened 1 new position and closed 0 in Q4 2025.
  • Euclidean Capital's portfolio value rose 55% quarter-over-quarter to $369M.

Based on Euclidean Capital's 13F filing for Q4 2025, filed 17 Feb 2026.